These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oxygen Nanobubble Tracking by Light Scattering in Single Cells and Tissues. Bhandari P; Wang X; Irudayaraj J ACS Nano; 2017 Mar; 11(3):2682-2688. PubMed ID: 28267921 [TBL] [Abstract][Full Text] [Related]
3. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors. Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514 [TBL] [Abstract][Full Text] [Related]
5. Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study. Song W; Luo Y; Zhao Y; Liu X; Zhao J; Luo J; Zhang Q; Ran H; Wang Z; Guo D Nanomedicine (Lond); 2017 May; 12(9):991-1009. PubMed ID: 28327075 [TBL] [Abstract][Full Text] [Related]
6. SPIO nanoparticle-stabilized PAA-F127 thermosensitive nanobubbles with MR/US dual-modality imaging and HIFU-triggered drug release for magnetically guided in vivo tumor therapy. Huang HY; Hu SH; Hung SY; Chiang CS; Liu HL; Chiu TL; Lai HY; Chen YY; Chen SY J Control Release; 2013 Nov; 172(1):118-127. PubMed ID: 23933522 [TBL] [Abstract][Full Text] [Related]
7. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer. Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393 [TBL] [Abstract][Full Text] [Related]
8. Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer. Yang H; Zhao P; Zhou Y; Li Q; Cai W; Zhao Z; Shen J; Yao K; Duan Y Sci Rep; 2021 Mar; 11(1):6254. PubMed ID: 33737559 [TBL] [Abstract][Full Text] [Related]
9. Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents. Wu H; Rognin NG; Krupka TM; Solorio L; Yoshiara H; Guenette G; Sanders C; Kamiyama N; Exner AA Ultrasound Med Biol; 2013 Nov; 39(11):2137-46. PubMed ID: 23932272 [TBL] [Abstract][Full Text] [Related]
10. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy. Erdogar N; İskit AB; Eroglu H; Sargon MF; Mungan NA; Bilensoy E Int J Pharm; 2014 Aug; 471(1-2):1-9. PubMed ID: 24836669 [TBL] [Abstract][Full Text] [Related]
11. Cyanine 5.5 conjugated nanobubbles as a tumor selective contrast agent for dual ultrasound-fluorescence imaging in a mouse model. Mai L; Yao A; Li J; Wei Q; Yuchi M; He X; Ding M; Zhou Q PLoS One; 2013; 8(4):e61224. PubMed ID: 23637799 [TBL] [Abstract][Full Text] [Related]
12. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. Wang Y; Li X; Zhou Y; Huang P; Xu Y Int J Pharm; 2010 Jan; 384(1-2):148-53. PubMed ID: 19781609 [TBL] [Abstract][Full Text] [Related]
13. Novel dual-mode nanobubbles as potential targeted contrast agents for female tumors exploration. Yang H; Zhou T; Cai W; Yi X; Liu X; Wang Y; Zhang L; Duan Y Tumour Biol; 2016 Oct; 37(10):14153-14163. PubMed ID: 27539728 [TBL] [Abstract][Full Text] [Related]
14. Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation. Perera RH; Solorio L; Wu H; Gangolli M; Silverman E; Hernandez C; Peiris PM; Broome AM; Exner AA Pharm Res; 2014 Jun; 31(6):1407-17. PubMed ID: 23943542 [TBL] [Abstract][Full Text] [Related]
15. Intravesical electromotive drug administration for non-muscle invasive bladder cancer. Jung JH; Gudeloglu A; Kiziloz H; Kuntz GM; Miller A; Konety BR; Dahm P Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011864. PubMed ID: 28898400 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy. Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction. Fan X; Wang L; Guo Y; Xiong X; Zhu L; Fang K Int J Nanomedicine; 2016; 11():3585-96. PubMed ID: 27536100 [TBL] [Abstract][Full Text] [Related]
18. Time-intensity-curve Analysis and Tumor Extravasation of Nanobubble Ultrasound Contrast Agents. Wu H; Abenojar EC; Perera R; De Leon AC; An T; Exner AA Ultrasound Med Biol; 2019 Sep; 45(9):2502-2514. PubMed ID: 31248638 [TBL] [Abstract][Full Text] [Related]
19. Concurrent visual and acoustic tracking of passive and active delivery of nanobubbles to tumors. Pellow C; Abenojar EC; Exner AA; Zheng G; Goertz DE Theranostics; 2020; 10(25):11690-11706. PubMed ID: 33052241 [No Abstract] [Full Text] [Related]
20. Oxygen supersaturated fluid using fine micro/nanobubbles. Matsuki N; Ishikawa T; Ichiba S; Shiba N; Ujike Y; Yamaguchi T Int J Nanomedicine; 2014; 9():4495-505. PubMed ID: 25285003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]